Detalles de la búsqueda
1.
Prevalence and trends in persistent symptoms following COVID-19 in Japan: A nationwide cross-sectional survey.
J Infect Chemother;
2024 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38346670
2.
Sotos syndrome with marked overgrowth in three Japanese patients with heterozygous likely pathogenic NSD1 variants: case reports with review of literature.
Endocr J;
71(1): 75-81, 2024 Jan 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37989294
3.
Intravenous methylprednisolone pulse therapy and the risk of in-hospital mortality among acute COVID-19 patients: Nationwide clinical cohort study.
Crit Care;
27(1): 53, 2023 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36755340
4.
Association between hospital internal medicine physician workforce and patient admissions during the COVID-19 pandemic in Japan.
BMC Health Serv Res;
23(1): 65, 2023 Jan 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36681836
5.
Estimating nationwide cases of sexually transmitted diseases in 2015 from sentinel surveillance data in Japan.
BMC Infect Dis;
20(1): 77, 2020 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-31992256
6.
Association of severe abnormal behavior and acetaminophen with/without neuraminidase inhibitors.
J Infect Chemother;
25(6): 423-426, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30744989
7.
Species differences in circulation and inflammatory responses in children with common respiratory adenovirus infections.
J Med Virol;
90(5): 873-880, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29350418
8.
Incidence of and Ivermectin Prescription Trends for COVID-19 in Japan.
J Gen Intern Med;
38(4): 1078-1080, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36323824
9.
Lessons Learned from Ivermectin.
J Gen Intern Med;
38(6): 1555, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36849865
10.
Severe abnormal behavior incidence after administration of neuraminidase inhibitors using the national database of medical claims.
J Infect Chemother;
24(3): 177-181, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29273435
11.
Comment on: Risk of neuropsychiatric adverse events associated with the use of oseltamivir: a nationwide population-based case-crossover study.
J Antimicrob Chemother;
74(6): 1762-1764, 2019 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30958534
12.
Number of sentinel medical institutions needed for estimating prefectural incidence in influenza surveillance in Japan.
J Epidemiol;
24(3): 183-92, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24584400
13.
Abnormal behavior during influenza in Japan during the last seven seasons: 2006-2007 to 2012-2013.
J Infect Chemother;
20(12): 789-93, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25284815
14.
Usefulness of a pluralistic approach in sentinel surveillance: seasonal influenza activity based on case counts per sentinel site in the National Epidemiological Surveillance of Infectious Diseases Program and test counts, case counts, and test positivity from the National Hospital Organization.
Jpn J Infect Dis;
2024 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38556302
15.
Association of Individual Behaviors With Infection Prevention Measures and COVID-19 Development: A Japanese Cross-Sectional Study.
Asia Pac J Public Health;
: 10105395241245496, 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38600739
16.
Risk of Underlying Diseases and Effectiveness of Drugs on COVID-19 Inpatients Assessed Using Medical Claims in Japan: Retrospective Observational Study.
Int J Gen Med;
16: 657-672, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36851998
17.
Analysis of hydroxychloroquine prescriptions for COVID-19 in Japan.
J Gen Fam Med;
24(3): 199-200, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37261051
18.
Comparing clinical outcomes of ARB and ACEi in patients hospitalized for acute COVID-19.
Sci Rep;
13(1): 11810, 2023 07 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37479767
19.
Prolonged Symptoms after COVID-19 in Japan: A Nationwide Survey of the Symptoms and Their Impact on Patients' Quality of Life.
Am J Med;
2023 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37236416
20.
Post-COVID health-related quality of life and somatic symptoms: A national survey in Japan.
Am J Med Sci;
366(2): 114-123, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37120076